Market Tracker

04/27 5:44am ET

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.2402
Delayed Data
As of Apr 24
 -0.0078 / -3.15%
Today’s Change
0.21
Today|||52-Week Range
0.40
-3.92%
Year-to-Date

Today’s Trading

Previous close0.25
Today’s open0.25
Day’s range-- - --
Volume2,057,711
Average volume (3 months)2,008,822
Market cap$51.7M
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+31.33%
P/E ratioNM
Price/Sales238.95
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.05-3.34%
ONTXOnconova Therapeutic...-0.05-2.09%
OGXIOncoGenex Pharmaceut...+0.04+1.86%
IMNPImmune Pharmaceutica...-0.02-1.00%
Data as of 04/24/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$197.0K
Annual profit (last year)-$17.5M
Net profit margin-8,857.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CSO
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts